GLENMEDE TRUST CO NA - CUBIST PHARMACEUTICALS INC ownership

CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 1 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2008. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$5,0000.0%800.0%0.00%
Q1 2014$5,0000.0%800.0%0.00%
Q4 2013$5,000
-99.6%
80
-99.9%
0.00%
-100.0%
Q4 2010$1,318,000
-9.6%
61,628
-1.2%
0.23%
-18.9%
Q3 2010$1,458,000
+10.0%
62,373
-3.2%
0.28%
+0.7%
Q2 2010$1,326,000
-7.5%
64,406
+1.2%
0.28%
+3.7%
Q1 2010$1,434,000
+18.8%
63,6610.0%0.27%
+13.0%
Q4 2009$1,207,000
-18.4%
63,661
-13.1%
0.24%
-21.5%
Q3 2009$1,479,000
+11.5%
73,260
+1.2%
0.30%
-2.9%
Q2 2009$1,326,000
+16.5%
72,360
+4.0%
0.31%
-3.4%
Q1 2009$1,138,000
-35.0%
69,575
-4.1%
0.32%
-27.4%
Q4 2008$1,752,000
+7.6%
72,523
-1.1%
0.44%
+41.7%
Q3 2008$1,629,000
+538.8%
73,320
+411.9%
0.31%
+597.8%
Q2 2008$255,000
+5.4%
14,322
+8.7%
0.04%
+21.6%
Q1 2008$242,000
-12.9%
13,1720.0%0.04%
-2.6%
Q3 2007$278,000
-4.5%
13,172
-11.1%
0.04%
-5.0%
Q2 2007$291,00014,8100.04%
Other shareholders
CUBIST PHARMACEUTICALS INC shareholders Q4 2008
NameSharesValueWeighting ↓
Palo Alto Investors LP 1,336,136$92,020,0008.58%
Cormorant Asset Management, LP 400,000$27,548,0008.00%
HealthCor Management, L.P. 1,400,000$96,418,0005.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,000,000$68,870,0003.57%
SECTOR GAMMA AS 176,090$12,127,0003.27%
EAGLE BOSTON INVESTMENT MANAGEMENT INC 698,376$48,097,0002.33%
Ghost Tree Capital, LLC 50,000$3,444,0002.12%
Duquesne Family Office 413,000$28,443,0001.90%
Rail-Splitter Capital Management, LLC 78,900$5,434,0001.88%
MAZAMA CAPITAL MANAGEMENT INC 50,891$3,505,0001.74%
View complete list of CUBIST PHARMACEUTICALS INC shareholders